3-溴呋喃并[3,2-c]吡啶-4-胺 | 799293-73-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 呋喃吡啶类
• 中文名称: 3-溴呋喃并[3,2-c]吡啶-4-胺
• 中文别名: 3-溴呋喃并[3,2-C]吡啶-4-胺
• 英文名称: 3-bromofuro[3,2-c]pyridin-4-amine
• CAS: 799293-73-5
• 化学式: C₇H₅BrN₂O
• 分子量: 213.033
• InChiKey: OAWQPZKVGXRJSX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  52
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2934999090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  3-溴呋喃并[3,2-c]吡啶-4-胺 在 N-溴代丁二酰亚胺(NBS) 、 四(三苯基膦)钯 、 sodium carbonate 作用下， 以 四氢呋喃 、 乙二醇二甲醚 为溶剂， 生成 4-amino-3-(4-((2-fluoro-5-(trifluoromethyl)aminocarbonylamino)phenyl)-7-(3-chlorophenyl))-furo[3,2-c]pyridine
  参考文献：
  名称：

  Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases

  摘要：

  A novel class of 3,7-diphenyl-4-amino-thieno and furo[3,2-c]pyridine has been designed based on pharmacophore models of ATP competitive kinase inhibitors. Versatile synthetic methods via double Suzuki coupling to explore SAR have been established and potent inhibitors against angiogenetic targets, VEGFR2, Tie-2, and EphB4, have been successfully discovered. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.09.050
• 作为产物：
  描述：

  4,5-二氢-4-氧代呋喃[3,2]吡啶 在 ammonium hydroxide 、 溴 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 三氯氧磷 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 四氯化碳 为溶剂， 生成 3-溴呋喃并[3,2-c]吡啶-4-胺
  参考文献：
  名称：

  Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases

  摘要：

  A novel class of 3,7-diphenyl-4-amino-thieno and furo[3,2-c]pyridine has been designed based on pharmacophore models of ATP competitive kinase inhibitors. Versatile synthetic methods via double Suzuki coupling to explore SAR have been established and potent inhibitors against angiogenetic targets, VEGFR2, Tie-2, and EphB4, have been successfully discovered. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.09.050

文献信息

• Thienopyridine and furopyridine kinase inhibitors
  申请人：Betschmann Patrick

  公开号：US20050026944A1

  公开（公告）日：2005-02-03

  Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

  具有以下化学式的化合物对抑制蛋白酪氨酸激酶具有用处。本发明还公开了制备这些化合物的方法、含有这些化合物的组合物，以及使用这些化合物进行治疗的方法。
• [EN] N-(SUBSTITUTED-PHENYL)-SULFONAMIDE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE N-(PHÉNYL SUBSTITUÉ)-SULFONAMIDE EN TANT QU'INHIBITEURS DE KINASE
  申请人：NERVIANO MEDICAL SCIENCES SRL

  公开号：WO2017220477A1

  公开（公告）日：2017-12-28

  The invention relates to N-(substituted-phenyl)-sulfonamide compounds, which are extremely useful as inhibitors of protein kinases (e.g. PERK kinase) and accordingly can be used for the treatment of cell proliferative disorders, such as cancer, or diseases associated with activated unfolded protein response pathways, such as Alzheimer's disease. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing pharmaceutical compositions comprising these compounds.

  这项发明涉及N-(取代苯基)-磺酰胺化合物，这些化合物作为蛋白激酶（例如PERK激酶）的抑制剂非常有用，因此可用于治疗细胞增殖异常（如癌症）或与激活的未折叠蛋白反应途径相关的疾病，如阿尔茨海默病。本发明还提供了制备这些化合物的方法、包含这些化合物的药物组合物、以及利用包含这些化合物的药物组合物治疗疾病的方法。
• Novel chemical compounds
  申请人：Miyazaki Yasushi

  公开号：US20080182868A1

  公开（公告）日：2008-07-31

  This invention relates to newly identified compounds for treating and preventing tumors and cancers, and methods for treating proliferative diseases associated with the imbalance or inappropriate activity of tyrosine kinases implicated in proliferative diseases.

  本发明涉及治疗和预防肿瘤和癌症的新型化合物，以及用于治疗与参与增殖性疾病的酪氨酸激酶失衡或不适当活性相关的增殖性疾病的方法。
• THIENOPYRIDINE AND FUROPYRIDINE KINASE INHIBITORS
  申请人：Betschmann Patrick

  公开号：US20070155776A1

  公开（公告）日：2007-07-05

  Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

  具有化学式的化合物对于抑制蛋白质酪氨酸激酶具有用处。本发明还公开了制备该化合物的方法、含有该化合物的组合物以及使用该化合物的治疗方法。
• Indazole compounds
  申请人：Ericsson M. Anna

  公开号：US20070282101A1

  公开（公告）日：2007-12-06

  Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.

  本发明提供了化合物(I)或其药学上可接受的盐、前药和生物活性代谢物，其中取代基如定义所述，这些化合物可用作治疗剂。